CLINICAL_TRIALS
trial_result
· 2026-04-03
Clinical Trial Update: PRV-3279-2a Trial in Systemic Lupus [Phase 2]
Summary
Provention Bio's PRV-3279-2a Phase 2 trial for systemic lupus erythematosus was terminated, with results posted on 2026-04-03.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Provention Bio, a Sanofi Company | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED | Results posted: 2026-04-03